Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 2
1950 2
1951 3
1952 4
1953 1
1954 7
1955 3
1956 5
1957 7
1959 4
1960 3
1961 5
1962 4
1963 9
1964 7
1965 1
1966 11
1967 2
1968 5
1969 4
1970 9
1971 5
1972 8
1973 8
1974 9
1975 4
1976 6
1977 5
1978 8
1979 6
1980 6
1981 4
1982 4
1983 11
1984 3
1985 1
1986 1
1987 6
1988 3
1989 5
1990 3
1991 5
1992 5
1993 10
1994 7
1995 4
1996 2
1997 3
1998 4
1999 9
2000 2
2001 2
2002 2
2003 1
2004 2
2005 3
2006 4
2007 2
2008 3
2009 2
2010 2
2011 8
2012 6
2013 7
2014 5
2015 7
2016 6
2017 3
2018 5
2019 4
2020 8
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

330 results
Results by year
Filters applied: . Clear all
Page 1
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.
Kim D, Robertson JS, Excler JL, Condit RC, Fast PE, Gurwith M, Pavlakis G, Monath TP, Smith J, Wood D, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Kim D, et al. Among authors: robertson js. Vaccine. 2020 Jul 22;38(34):5556-5561. doi: 10.1016/j.vaccine.2020.06.017. Epub 2020 Jun 19. Vaccine. 2020. PMID: 32571717 Free PMC article. Review.
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.
Monath TP, Fast PE, Modjarrad K, Clarke DK, Martin BK, Fusco J, Nichols R, Heppner DG, Simon JK, Dubey S, Troth SP, Wolf J, Singh V, Coller BA, Robertson JS; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Monath TP, et al. Among authors: robertson js. Vaccine X. 2019 Jan 29;1:100009. doi: 10.1016/j.jvacx.2019.100009. eCollection 2019 Apr 11. Vaccine X. 2019. PMID: 31384731 Free PMC article.
The INN global nomenclature of biological medicines: A continuous challenge.
Robertson JS, Chui WK, Genazzani AA, Malan SF, López de la Rica Manjavacas A, Mignot G, Thorpe R, Balocco R, Rizzi M. Robertson JS, et al. Biologicals. 2019 Jul;60:15-23. doi: 10.1016/j.biologicals.2019.05.006. Epub 2019 May 23. Biologicals. 2019. PMID: 31130314 Free article. Review.
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.
Kochhar S, Kim D, Excler JL, Condit RC, Robertson JS, Drew S, Whelan M, Wood D, Fast PE, Gurwith M, Klug B, Khuri-Bulos N, Smith ER, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Kochhar S, et al. Among authors: robertson js. Vaccine. 2020 Jul 31;38(35):5734-5739. doi: 10.1016/j.vaccine.2020.06.044. Epub 2020 Jul 9. Vaccine. 2020. PMID: 32653276 Free PMC article. Review.
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines.
Condit RC, Kim D, Robertson JS, Excler JL, Gurwith M, Monath TP, Pavlakis G, Fast PE, Smith J, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Benefit-Risk Assessment of Vaccines by Technology (BRAVATO) Working Group. Electronic address: bc-coordinator@taskforce.org. Condit RC, et al. Among authors: robertson js. Vaccine. 2020 Nov 17;38(49):7708-7715. doi: 10.1016/j.vaccine.2020.08.009. Epub 2020 Sep 6. Vaccine. 2020. PMID: 32907759 Free PMC article. Review.
Plant Genome Duplication Database.
Lee TH, Kim J, Robertson JS, Paterson AH. Lee TH, et al. Among authors: robertson js. Methods Mol Biol. 2017;1533:267-277. doi: 10.1007/978-1-4939-6658-5_16. Methods Mol Biol. 2017. PMID: 27987177
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
Gurwith M, Condit RC, Excler JL, Robertson JS, Kim D, Fast PE, Drew S, Wood D, Klug B, Whelan M, Mallett Moore T, Khuri-Bulos N, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG. Gurwith M, et al. Among authors: robertson js. Vaccine. 2020 Nov 17;38(49):7702-7707. doi: 10.1016/j.vaccine.2020.09.042. Epub 2020 Oct 16. Vaccine. 2020. PMID: 33070999 Free PMC article. Review.
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
Kochhar S, Excler JL, Kim D, Robertson JS, Fast PE, Condit RC, Drew S, Wood D, Gurwith M, Klug B, Whelan M, Khuri-Bulos N, Mallett Moore T, Smith ER, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Electronic address: brightoncollaborationv3swg@gmail.com. Kochhar S, et al. Among authors: robertson js. Vaccine. 2020 Sep 3;38(39):6184-6189. doi: 10.1016/j.vaccine.2020.07.028. Epub 2020 Jul 31. Vaccine. 2020. PMID: 32747214 Free PMC article.
330 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page